"A lot has been written and a lot said about us. We generally don't respond and believe in just doing what is right for the team, the shareholders and the company and just out-execute. It's easier to write about companies as they are 'entities at the end'. We tend to forget that at the end, these entities are made by real people with real sweat, blood, tears and a lot more!"
"The rights issue, which allows existing investors to buy new shares in the firm at a much lower valuation, was oversubscribed, PharmEasy co-founder Dharmil Sheth said in a LinkedIn post. A regulatory filing showed at the time that the startup had secured about $216 million."
Collection
[
|
...
]